All In MedTech

Device Trial Radar · NCT02284711

Impact of Salpingectomy on Ovarian Reserve

Impact of Salpingectomy on Ovarian Reserve, With Comparison Between Two Coagulation Techniques

Last checked: Nov 20, 2026Latest source record: Sep 2, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

96

Actual

Start

Mar 9, 2015

Primary completion

Oct 16, 2020

Study completion Oct 16, 2020

Sponsor

Lead sponsor
Hospices Civils de LyonAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Nov 6, 2014

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Prevention
Who can join
Female only, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Epithelial cancer of the ovaries is the most severe form of gynecologic cancer; a significant proportion of ovarian cancers originate from the Fallopian tube. Guidelines therefore now recommend systematically associating prophylactic salpingectomy to benign hysterectomy. The principal objective of the present study is to assess the impact of salpingectomy on ovarian reserve by anti-Müllerian hormone (AMH) assay and calculating the Doppler index of vascular resistance in the ovarian vessels. The secondary objective is to compare ovarian reserve results between two coagulation techniques used in salpingectomy: bipolar electric energy versus ultrasound. The study design is single-center, prospective, before-and-after, with open randomization between two groups defined by coagulation technique.

Conditions

  • Laparoscopic Salpingectomy

Interventions

  • Bipolar electric energyDevice

    Coagulation during salpingectomy using conventional bipolar electric energy

  • ultrasound energyDevice

    Coagulation during salpingectomy using UltraCision HARMONIC ACE® ultrasound energy

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. AMH levelTime frame: 3 months post-surgery

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Hospices Civils de Lyon - HFME

    Lyon, France

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.